Breaking News Headlines Today | Ground News

See every side of every news story

pharmatimes.com image

News from pharmatimes.com

Top pharmatimes.com News

Rezatapopt Yields Responses Across TP53 Y220C-Mutated Solid Tumor Types

Rezatapopt Yields Responses Across TP53 Y220C-Mutated Solid Tumor Types

Rezatapopt achieved an ORR of 33% in all patients, and an ORR of 43% in patients with ovarian cancer, with 1 confirmed complete response.See the Story

Quotient Sciences Partners with CPI to Enhance RNA Therapy Development and Production Efficiency

United Kingdom · United Kingdom

Quotient Sciences Partners with CPI to Enhance RNA Therapy Development and Production Efficiency

Quotient Sciences has announced a collaboration with th […] The post Quotient Sciences Partners with CPI to Enhance RNA Therapy Development and Production Efficiency first appeared on GeneOnline News. The post Quotient Sciences Partners with CPI to Enhance RNA Therapy Development and Production Efficiency appeared first on GeneOnline News.See the Story

First Patient Enrolled in Phase 3 Study for Hepatitis D Treatment

First Patient Enrolled in Phase 3 Study for Hepatitis D Treatment

Bluejay Therapeutics’ investigational therapy, brelovitug, offers weekly self-administered injections and will be studied against the only approved treatment outside the US.See the Story

Breaking News Topics Related to pharmatimes.com